DexCom, Inc. (NasdaqGS:DXCM) said it isn't active merger talks, sending the stock up more than 8% after news reports last week that the company was in talks to buy Insulet Corporation (NasdaqGS:PODD). "We do not intend to comment further on this topic and we assume no obligation to make any further announcement or disclosure should circumstances change," Dexcom said.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
174.4 USD | +0.58% | +4.96% | -19.61% |
Mar. 20 | US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady | MT |
Mar. 20 | Insulet Names Ana Maria Chadwick Finance Chief | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.61% | 12.21B | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Dexcom Says Not in Active Merger Talks